Paul A. Howard

Grundare på

Limulus Management Co. LLC

Health Technology

Finance

Consumer Services

Profil

Mr. Paul A. Howard is Founding Partner at Mediphase Venture Partners.
He is on the Board of Directors at Serenex, Inc. Mr. Howard was a Senior Vice President at Hambrecht & Quist Capital Management in Boston from 1992-1999, where he was responsible for managing the fund's biotechnology investments.
From 1983-1990, he was a Senior Technical Sales Executive for the Miles Biotechnology Division of Bayer A.G.
Mr. Howard earned an AB from Bowdoin College in 1981, an MS from the University of Massachusetts, Amherst in 1983, and an S.M.
from the Sloan School of Management at M.I.T.
in 1992.
He serves on the Board of Directors of Supplemental Health Care and Serenex.

Aktiva positioner av Paul A. Howard

Företag	Position	Start
Limulus Management Co. LLC Limulus Management Co. LLC Investment ManagersFinance Limulus Management Co LLC invests in healthcare/life science companies located in the US. The firm focuses on companies with intellectual property positions and growth potential. It targets companies operating in the fields of biopharmaceutical technology and life sciences information. It provides financing for early stage capital requirements with an investment size ranging from $4 to $8 million.	Grundare	2011-01-03
Wellpartner LLC Wellpartner LLC Medical DistributorsDistribution Services Provides pharmacy distribution solutions and contract pharmacy administration services	Direktör/Styrelseledamot	-

Alla aktiva positioner av Paul A. Howard

Tidigare kända positioner av Paul A. Howard

Företag	Position	Slut
Tekla Capital Management LLC Tekla Capital Management LLC Investment ManagersFinance Tekla primarily focuses on healthcare investing. Their funds invest in public and private growth equities in the healthcare and life sciences industries.	Portföljförvaltare-Aktier	1998-12-31
Bayer AG /Plasma Products Business/ Bayer AG /Plasma Products Business/ Pharmaceuticals: MajorHealth Technology Provides plasma products	Företagsledare/Principal	1989-12-31
TETRAPHASE PHARMACEUTICALS, INC.	Direktör/Styrelseledamot	-
Serenex, Inc. Serenex, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops drugs	Direktör/Styrelseledamot	-

Se detaljerna i Paul A. Howards erfarenhet

Paul A. Howards utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Paul A. Howards erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	9
Serenex, Inc. Serenex, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops drugs	Health Technology
Tetraphase Pharmaceuticals, Inc. Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics	Health Technology
Tekla Capital Management LLC Tekla Capital Management LLC Investment ManagersFinance Tekla primarily focuses on healthcare investing. Their funds invest in public and private growth equities in the healthcare and life sciences industries.	Finance
Wellpartner LLC Wellpartner LLC Medical DistributorsDistribution Services Provides pharmacy distribution solutions and contract pharmacy administration services	Distribution Services
Massachusetts Institute of Technology Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University	Finance
Bowdoin College Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Bayer AG /Plasma Products Business/ Bayer AG /Plasma Products Business/ Pharmaceuticals: MajorHealth Technology Provides plasma products	Health Technology
University of Massachusetts University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Limulus Management Co. LLC Limulus Management Co. LLC Investment ManagersFinance Limulus Management Co LLC invests in healthcare/life science companies located in the US. The firm focuses on companies with intellectual property positions and growth potential. It targets companies operating in the fields of biopharmaceutical technology and life sciences information. It provides financing for early stage capital requirements with an investment size ranging from $4 to $8 million.	Finance